Clinical Trials Directory

Trials / Completed

CompletedNCT02122510

Transverse Abdominal Block for Analgesia in Casarean Section

The Value of Preemptive Dexmedetomidine Transversus Abdominis Plane (TAP) Block in Patients Undergoing Elective Cesarean Section Under General Anesthesia.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Tanta University · Academic / Other
Sex
Female
Age
21 Years – 40 Years
Healthy volunteers
Not accepted

Summary

In this study, the investigators will compare the analgesic effect of bupivacaine and bupivacaine-dexmetomedine after elective cesarean delivery by performing an bilateral TAP block, on the patients for whom the operation will be performed under general anesthesia.

Detailed description

The investigators will study 60 ASA \[American Society of Anesthesiologist\] physical status I and ІІ patients undergoing elective cesarean delivery at tanta University Hospital, in a prospective, randomized, comparative, clinical trial. Patients will be randomly allocated to two equal groups (n = 30) using closed envelopes labeled 1,and 2 reflecting group 1and 2 respectively. The drugs are prepared by the anesthesiologist who is not involved in the study or data collection. Group I: (n=30) will receive pre-delivery bilateral TAP block with 10 ml of bupivacaine 0.5 % mixed with 10 ml saline and 10 μg dexmetonedine in 20 ml syringe labeled G 2. Group II: (n=30) will receive post-delivery bilateral TAP block with 10 ml of bupivacaine 0.5 % mixed with 10 ml saline in 20 ml syringe labeled G2.

Conditions

Interventions

TypeNameDescription
DRUGBupivacine groupBupivacaine group(n=30) will receive post-delivery bilateral TAP block with 10 ml of bupivacaine 0.5 % mixed with 10 ml saline and 10 μg dexmetonedine in 20 ml syringe
DRUGDexmedetomidineDexamedtomedine group will receive post-delivery bilateral TAP block with 10 ml of bupivacaine 0.5 % mixed with 10 ml saline and 10 μg dexmetonedine in 20 ml syringe

Timeline

Start date
2013-03-01
Primary completion
2014-05-01
Completion
2014-06-01
First posted
2014-04-24
Last updated
2014-12-16

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT02122510. Inclusion in this directory is not an endorsement.